Establishment of transplantable murine osteosarcoma cell line with endochondral ossification

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1627-1631

  Nishi, Takashi ^a   Kusumi, Tomomi ^a   Tanaka, Masanori ^a   Sato, Fuyuki ^a   Sasaki, Mutsuo ^a   Kudo, Hajime ^a   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cell line; Endochondral ossification; Murine osteosarcoma; Osteoblastic differentiation; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CELL STRUCTURE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; FEMALE; LUNG METASTASIS; METASTASIS POTENTIAL; MONOLAYER CULTURE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROCYTES; FEMALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSSIFICATION, HETEROTOPIC; OSTEOSARCOMA; SOFT TISSUE NEOPLASMS;

EID: 45949084533     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kumar V, Abbas AK and Fausto N (eds.) Robbins and Cotran Pathologic Basis of Disease, 7th Ed. Philadelphia; Elsevier Saunders, pp. 1294-1296, 2005.
2. Majeska RJ: Culture of osteoblastic cells. In: Principles of Bone Biology. Bilezikian JP, Raisz LG and Rodan GA (eds.). San Diego; Academic Press, pp. 1229-1237, 1996.
3. Majeska RJ, Rodan SB and Rodan GA: Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107: 1494-1503, 1980.
4. Partridge NC, Alcorn D, Michelangeli VP, Ryan G and Martin TJ: Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 43: 4308-4314, 1983.
5. Kawai A: A newly established human osteosarcoma cell line with osteoblastic properties. Clin Orthop 259: 256-267, 1990.
6. Ogose A, Motoyama T, Hotta T, Watanabe H and Takahashi HE: Bone formation in vitro and in nude mice by human osteosarcoma cells. Virchows Arch 426: 117-125, 1995.
7. Satonaka H, Kusuzaki K, Matsubara T, Shintani K, Wakabayashi T, Nakamura T, Matsumine A and Uchida A: Flash wave light strongly enhanced the cytocidal effect of photodynamic therapy with acridine orange on a mouse osteosarcoma cell line. Anticancer Res 27: 3339-3344, 2007.
8. Matsui TA, Murata H, Sakabe T, Sowa Y, Horie N, Nakanishi R, Sakai T and Kubo T: Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. Oncol Rep 18: 1263-1268, 2007.
9. Nakayama, T, Kanoe, H, Sasaki MS, Aizawa S, Nakamura T and Toguchida J: Establishment of an osteoblast-like cell line, MMC2, from p53-deficient mice. Bone 21: 313-319, 1997.
10. Schmidt J, Strauß GP, Schön A, Luz A, Murray AB, Melchiori A, Aresu O and Erfle V: Establishment and characterization of osteogenic cell lines from a spontaneous murine osteosarcoma. Differentiation 39: 151-160, 1988.
11. Dunn TB and Andervont HB: Histology of some neoplasms and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J Nat Cancer Inst 31: 873-901, 1963.
12. Kijima H and Scanlon KJ: Ribozyme as an approach for growth suppression of human pancreatic cancer. Mol Biotechnol 14: 59-72, 2000.
13. Schajowictz F, Ackerman LV, Adler CP, Bertoni F, Donato de Próspero J, Martínez Tello FJ, Mazabraud A, Matsuno T, Povysil C, Salzer-Kuntschik M, Sissons HA, Sobin LH and Unni KK: Bone-forming tumours. In: Histological Typing of Bone Tumours, 2nd Ed. World Health Organization, International Histological Classification of Tumours. Schajowitz F (ed.). Berlin; Springer-Verlag, pp. 7-13, 1993.
14. Enzinger FM and Weiss SW: Osseous soft tissue tumors. In: Soft tissue tumors, 3rd Ed. Enzinger, FM and Weiss SW (eds.). St. Louis; Mosby, pp. 1013-1037, 1995.
15. Koshkina NV, Khanna C, Mendoza A, Guan H, DeLauter L and Kleinermann ES: Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Mol Cancer Res 5: 991-999, 2007.
16. Okamoto K, Oshika Y, Fukushima Y, Ohnishi Y, Tokunaga T, Tomii Y, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N and Nakumura M: Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189. Oncol Rep 6: 1201-1204, 1999.
17. Tokunaga T, Kijima H, Oshika Y, Fukushima Y, Abe Y, Ohnishi Y, Yamazaki H, Tsuchida T, Makuuchi H, Tamaoki N, Ueyama Y and Nakamura M: Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol Rep 5: 1115-1118, 1998.
18. Abe Y, Oshika Y, Ohnishi Y, Suto R, Tokunaga T, Yamazaki H, Kijima H, Hiraoka N, Ueyama Y, Tamaoki N and Nakamura M: A xenograft line of human teratocarcinoma established by serial transplantation in severe combined immunodeficient (SCID) mice. APMIS 105: 283-289, 1997.
19. Ueyama Y, Abe Y, Ohnishi Y, Sawa N, Hatanaka H, Handa A, Tokuda Y, Yamazaki H, Kijima H, Tamaoki N and Nakamura M: In vivo chemosensitivity of human malignant cystosarcoma phyllodes xenograft. Oncology Rep 7: 257-260, 2000.
20. Tashiro T, Inaba M, Kobayashi T, Sakurai Y, Maruo K, Ohnishi Y, Ueyama Y and Nomura T: Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses. Cancer Chemother Pharmacol 24: 187-192, 1989.
21. Inaba M, Kobayashi T, Tashiro T, Sakurai Y, Maruo K, Ohnishi Y, Ueyama Y and Nomura T: Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose. Cancer 64: 1577-1582, 1989.
22. Nishime C, Ohnishi Y, Suemizu H, Tamaoki N, Suematsu M, Oida Y, Yamazaki H, Nakamura M, Ueyama Y and Kijima H: Gallbladder small cell carcinoma xenograft established by serial transplantation in nude mice. Anticancer Res 26: 79-83, 2006.
23. Kijima H, Abe Y, Yamazaki H, Ohnishi Y, Ueyama Y, Tamaoki N and Nakamura M: Stability of ras oncogene mutation in the human tumor xenografts through serial passages. Anticancer Res 14: 2583-2587, 1994.
24. Masuda K, Kijima H, Kim HM, Han SB, Ohnishi Y, Sawa N, Oshika Y, Tokunaga T, Tsuchida T, Abe Y, Hamana T, Matsubayashi H, Yamazaki H, Tamaoki N, Ueyama Y and Nakamura M: Heterozygous ras mutations are preserved in serially passaged human tumor xenografts and established cell lines. Oncol Rep 6: 741-745, 1999.
25. Kusumi T, Nishi T, Tanaka M, Tsuchida S and Kudo H: A murine osteosarcoma cell line with a potential to develop ossification upon transplantation. Jpn J Cancer Res 92: 649-658, 2001.